Healthcare giant Henry Schein (NSDQ:HSIC) agreed to pay an undisclosed amount to acquire 5 dental businesses from Belgium-based Arseus, the companies announced this week.
Arseus
Derma Sciences CEO Quilty’s resignation from board appeases Nasdaq | Wall Street Beat
Derma Sciences (NSDQ:DSCI) president & CEO Edward Quilty resigned from the company’s board of directors, settling a non-compliance issue that could have led to delisting from the Nasdaq stock exchange.
Sorin’s 2011 profits rise despite flat sales | Earnings Roundup
Sorin Group (BIT:SRN) managed to raise its bottom line despite flat sales for 2011 by raising its gross margin via restructuring, posting a profit increase of 48.3% for the year.
The Milanese cardiovascular device maker reported profits of $75.2 million (~€58.0 million) on sales of $963.4 million (~€743.4 million), compared with profits of $50.7 million (~€39.1 million) on sales of $966.5 million (~€745.8 million) during 2010.